Prognostic significance of tumor-infiltrating T cells in ovarian cancer: A meta-analysis
Top Cited Papers
- 1 February 2012
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 124 (2) , 192-198
- https://doi.org/10.1016/j.ygyno.2011.09.039
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute (P01-CA83638)
This publication has 37 references indexed in Scilit:
- The emergence of immunomodulation: Combinatorial immunochemotherapy opportunities for the next decadeGynecologic Oncology, 2010
- Increased immunogenicity of surviving tumor cells enables cooperation between liposomal doxorubicin and IL-18Journal of Translational Medicine, 2009
- Intraepithelial CD8-positive T lymphocytes predict survival for patients with serous stage III ovarian carcinomas: relevance of clonal selection of T lymphocytesBritish Journal of Cancer, 2009
- Intraepithelial T cells and tumor proliferationCancer, 2009
- Intraepithelial T cells and prognosis in ovarian carcinoma: novel associations with stage, tumor type, and BRCA1 lossLaboratory Investigation, 2009
- Increased HLA-DMB Expression in the Tumor Epithelium Is Associated with Increased CTL Infiltration and Improved Prognosis in Advanced-Stage Serous Ovarian CancerClinical Cancer Research, 2008
- HLA Class I Antigen Processing Machinery Component Expression and Intratumoral T-Cell Infiltrate as Independent Prognostic Markers in Ovarian CarcinomaClinical Cancer Research, 2008
- Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+T lymphocytes are prognostic factors of human ovarian cancerProceedings of the National Academy of Sciences, 2007
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986